Actively Recruiting
Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Non-Randomized Controlled Parallel-Group Clinical Trial
Led by Universidad Autonoma de Nuevo Leon · Updated on 2026-03-27
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
Universidad Autonoma de Nuevo Leon
Lead Sponsor
H
Hospital Universitario Dr. Jose E. Gonzalez
Collaborating Sponsor
AI-Summary
What this Trial Is About
This trial investigates whether daily intake of cold-pressed pecan nut oil can reduce inflammation and improve metabolic health in adults with overweight. Researchers study key inflammatory markers like C-reactive protein, interleukin-6, and tumor necrosis factor-alpha, along with blood glucose and lipid profiles. The goal is to understand the impact of pecan nut oil supplementation on these health indicators compared to no intervention. Participants in the experimental group will take 30 mL of pecan nut oil daily for 8 weeks while maintaining their usual diet and physical activity. A control group will continue their normal lifestyle without supplementation. The study involves two evaluation visits at the start and end of the 60-day period, during which blood samples and body measurements will be collected. During the trial, participants will provide dietary information through 24-hour recalls and undergo assessments of inflammation, body weight, body fat, waist and hip circumference, and blood markers. Researchers will monitor changes in inflammatory biomarkers and metabolic parameters from baseline to day 60. The study lasts for about two months with careful monitoring of participants' health and adherence to the supplementation protocol.
CONDITIONS
Brief Title
Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 65 years
- Body mass index (BMI) 25 to less than 30 kg/m² (overweight)
- Willingness to participate and provide written informed consent
- Ability to comply with study procedures and attend scheduled visits
- Stable dietary habits and physical activity levels during the study period
You will not qualify if you...
- Diagnosis of chronic diseases such as diabetes mellitus, cardiovascular disease, liver disease, renal disease, or autoimmune disorders
- Use of anti-inflammatory medications, lipid-lowering drugs, or dietary supplements within the last 3 months
- Smoking or excessive alcohol consumption
- Pregnancy or lactation
- Known allergy or intolerance to nuts or nut-derived products
- Participation in another clinical trial within the last 3 months
- Any condition that may interfere with study participation or outcomes as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 60 days
Participants receive a daily oral supplementation of pecan nut oil at a standardized dose of 30 mL for 60 days or maintain their usual diet without supplementation in the control group. The intervention aims to evaluate the anti-inflammatory effects and impact on metabolic and biochemical parameters in adults with overweight.
2 visits (baseline and end of intervention)
Trial Site Locations
Total: 1 location
1
Facultad de Salud Pública y Nutrición, Universidad Autónoma de Nuevo León
Monterrey, Nuevo León, Mexico, 64460
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here